The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 2-naphthoate ID: ALA4063319
PubChem CID: 78805530
Max Phase: Preclinical
Molecular Formula: C17H15N3O4
Molecular Weight: 325.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C17H15N3O4/c1-12-18-11-16(20(22)23)19(12)8-9-24-17(21)15-7-6-13-4-2-3-5-14(13)10-15/h2-7,10-11H,8-9H2,1H3
Standard InChI Key: SHYYVRSTNCZLSM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
28.1548 -10.3430 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8134 -9.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5521 -9.0710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7283 -9.0860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4853 -9.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1650 -11.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6000 -10.0962 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2045 -9.5377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7799 -10.8975 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8818 -11.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8919 -12.3894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6088 -12.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6189 -13.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3155 -12.3718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.7076 -10.1342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9114 -14.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9212 -14.8474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3344 -14.0072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3476 -14.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6401 -15.2430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6503 -16.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3673 -16.4668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0754 -16.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0618 -15.2225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
1 6 1 0
7 8 2 0
7 9 1 0
2 7 1 0
6 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
5 15 1 0
13 16 2 0
16 17 1 0
17 20 2 0
19 18 2 0
18 13 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M CHG 2 7 1 9 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.32Molecular Weight (Monoisotopic): 325.1063AlogP: 3.11#Rotatable Bonds: 5Polar Surface Area: 87.26Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.27CX LogP: 3.03CX LogD: 3.03Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.41Np Likeness Score: -1.31
References 1. Salar U, Khan KM, Taha M, Ismail NH, Ali B, Qurat-Ul-Ain, Perveen S, Ghufran M, Wadood A.. (2017) Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives., 125 [PMID:27886546 ] [10.1016/j.ejmech.2016.11.031 ]